SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $78,126 | -31.5% | 2,073,970 | -10.5% | 0.26% | -30.4% |
Q1 2024 | $114,083 | -99.0% | 2,317,810 | +1024.9% | 0.38% | +1109.7% |
Q1 2022 | $11,629,000 | -50.5% | 206,054 | -45.6% | 0.03% | -42.6% |
Q4 2021 | $23,490,000 | +4.6% | 379,007 | +7.1% | 0.05% | 0.0% |
Q3 2021 | $22,453,000 | +499.5% | 353,916 | +678.7% | 0.05% | +500.0% |
Q2 2021 | $3,745,000 | +22.9% | 45,448 | +8.1% | 0.01% | +12.5% |
Q4 2020 | $3,048,000 | – | 42,032 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |